Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Janssen Diagnostics, LLC
Assay turn-around-time will be collected at sites that are using the GeneSearch BLN Assay for intraoperative testing of sentinel lymph nodes. The sites must be planning to use the assay result to guide the decision to complete an axillary lymph node dissection.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pre-operatively established diagnosis of invasive carcinoma of the breast
Scheduled for axillary sentinel lymph node dissection as per standard of care at the clinical site for newly diagnosed breast cancer patients
Patients for whom the GeneSearch™ BLN Assay will be used intra-operatively to make a decision for an axillary lymph node dissection
18 years of age or older
Female or male
You may not be if
Previous diagnosis of lymphoma
Subjects participating in other research studies that would interfere with their full participation in this study
Patients and/or conditions with 'interfering substances' as listed in the IFU
Patients who have had any pre-operative treatment for breast cancer including neoadjuvant and/or hormonal intervention such as aromatase inhibitors or tamoxifen
Clareo Health | GeneSearch Breast Lymph Node (BLN) Assay Timing Study
